Status:
COMPLETED
Novel Anxiety Treatment
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Cognitive Training
Anxiety Disorders
Eligibility:
All Genders
8-12 years
Phase:
NA
Brief Summary
The first aim of this study, as mentioned in the attached NIH grant, is to test the feasibility and acceptability of a novel computer-based cognitive training program that is designed to rehabilitate ...
Detailed Description
Children will be recruited through local schools, pediatricians' offices, and through Dr. Sylvester's child anxiety clinic by asking staff to present Institutional Review Board (IRB) approved recruitm...
Eligibility Criteria
Inclusion
- ages of 8-12
- have a current diagnosis of separation anxiety disorder, generalized anxiety disorder, and/or social phobia.
Exclusion
- prior diagnoses of attention deficit hyperactivity disorder (ADHD)
- autism spectrum disorder
- intellectual disability (IQ\<70)
- a significant medical problem
- current use of psychotropic medication other than selective serotonin reuptake inhibitor (SSRI) (children who are currently taking an SSRI and are still experiencing symptoms of anxiety will not be excluded).
Key Trial Info
Start Date :
February 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03790696
Start Date
February 2 2017
End Date
March 31 2020
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washinton University School of Medicine
St Louis, Missouri, United States, 63108